526 related articles for article (PubMed ID: 35510607)
1. Development of novel monoamine oxidase B (MAO-B) inhibitors by combined application of docking-based alignment, 3D-QSAR, ADMET prediction, molecular dynamics simulation, and MM_GBSA binding free energy.
El Aissouq A; Chedadi O; Bouachrine M; Ouammou A; Khalil F
J Biomol Struct Dyn; 2023 Jul; 41(10):4667-4680. PubMed ID: 35510607
[TBL] [Abstract][Full Text] [Related]
2. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
[TBL] [Abstract][Full Text] [Related]
3.
Shirvani P; Fassihi A
J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
[TBL] [Abstract][Full Text] [Related]
4. Computational investigation of unsaturated ketone derivatives as MAO-B inhibitors by using QSAR, ADME/Tox, molecular docking, and molecular dynamics simulations.
El Aissouq A; Bouachrine M; Ouammou A; Khalil F
Turk J Chem; 2022; 46(3):687-703. PubMed ID: 37720619
[TBL] [Abstract][Full Text] [Related]
5. In silico studies on p21-activated kinase 4 inhibitors: comprehensive application of 3D-QSAR analysis, molecular docking, molecular dynamics simulations, and MM-GBSA calculation.
Gao Y; Wang H; Wang J; Cheng M
J Biomol Struct Dyn; 2020 Sep; 38(14):4119-4133. PubMed ID: 31556340
[TBL] [Abstract][Full Text] [Related]
6. Chemical library design, QSAR modeling and molecular dynamics simulations of naturally occurring coumarins as dual inhibitors of MAO-B and AChE.
Boulaamane Y; Kandpal P; Chandra A; Britel MR; Maurady A
J Biomol Struct Dyn; 2024; 42(4):1629-1646. PubMed ID: 37199265
[TBL] [Abstract][Full Text] [Related]
7. Combined 3D-QSAR and docking analysis for the design and synthesis of chalcones as potent and selective monoamine oxidase B inhibitors.
Mellado M; González C; Mella J; Aguilar LF; Viña D; Uriarte E; Cuellar M; Matos MJ
Bioorg Chem; 2021 Mar; 108():104689. PubMed ID: 33571810
[TBL] [Abstract][Full Text] [Related]
8. Discerning of isatin-based monoamine oxidase (MAO) inhibitors for neurodegenerative disorders by exploiting 2D, 3D-QSAR modelling and molecular dynamics simulation.
Kumar S; Jayan J; Manoharan A; Benny F; Abdelgawad MA; Ghoneim MM; El-Sherbiny M; Thazhathuveedu Sudevan S; Aneesh TP; Mathew B
J Biomol Struct Dyn; 2024 Mar; 42(5):2328-2340. PubMed ID: 37261844
[TBL] [Abstract][Full Text] [Related]
9. Two dimensional-QSAR and molecular dynamics studies of a selected class of aldoxime- and hydroxy-functionalized chalcones as monoamine oxidase-B inhibitors.
Mathew B; Ravichandran V; Raghuraman S; Rangarajan TM; Abdelgawad MA; Ahmad I; Patel HM; Kim H
J Biomol Struct Dyn; 2023 Nov; 41(19):9256-9266. PubMed ID: 36411738
[TBL] [Abstract][Full Text] [Related]
10. Proposing Novel MAO-B Hit Inhibitors Using Multidimensional Molecular Modeling Approaches and Application of Binary QSAR Models for Prediction of Their Therapeutic Activity, Pharmacokinetic and Toxicity Properties.
Is YS; Durdagi S; Aksoydan B; Yurtsever M
ACS Chem Neurosci; 2018 Jul; 9(7):1768-1782. PubMed ID: 29671581
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Molecular Determinant of Reversible Human Monoamine Oxidase B Inhibitors Containing 2H-Chromen-2-One Core: Structure-Based and Ligand-Based Derived Three-Dimensional Quantitative Structure-Activity Relationships Predictive Models.
Mladenović M; Patsilinakos A; Pirolli A; Sabatino M; Ragno R
J Chem Inf Model; 2017 Apr; 57(4):787-814. PubMed ID: 28291352
[TBL] [Abstract][Full Text] [Related]
12. Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties.
Zhang Y; Chen L; Wang Z; Zhu Y; Jiang H; Xu J; Xiong F
J Biomol Struct Dyn; 2024 May; 42(8):4196-4213. PubMed ID: 37272892
[TBL] [Abstract][Full Text] [Related]
13. Field and atom-based 3D-QSAR models of chromone (1-benzopyran-4-one) derivatives as MAO inhibitors.
Saha M; Gupta S; Dhiman S; Asati V; Ali A; Ali A
J Biomol Struct Dyn; 2023; 41(21):12171-12185. PubMed ID: 36650997
[TBL] [Abstract][Full Text] [Related]
14. In silico discovery of potent and selective Janus kinase 3 (JAK3) inhibitors through 3D-QSAR, covalent docking, ADMET analysis, molecular dynamics simulations, and binding free energy of pyrazolopyrimidine derivatives.
Faris A; Hadni H; Ibrahim IM; Elhallaoui M
J Biomol Struct Dyn; 2024 Jun; 42(9):4817-4833. PubMed ID: 37338041
[TBL] [Abstract][Full Text] [Related]
15. In silico identification of 1,2,4-triazoles as potential Candida Albicans inhibitors using 3D-QSAR, molecular docking, molecular dynamics simulations, and ADMET profiling.
Bouamrane S; Khaldan A; Hajji H; El-Mernissi R; Alaqarbeh M; Alsakhen N; Maghat H; Ajana MA; Sbai A; Bouachrine M; Lakhlifi T
Mol Divers; 2023 Oct; 27(5):2111-2132. PubMed ID: 36239842
[TBL] [Abstract][Full Text] [Related]
16. Molecular modeling studies of pyrrolo[2,3-d]pyrimidin-4-amine derivatives as JAK1 inhibitors based on 3D-QSAR, molecular docking, molecular dynamics (MD) and MM-PBSA calculations.
Keretsu S; Bhujbal SP; Cho SJ
J Biomol Struct Dyn; 2021 Feb; 39(3):753-765. PubMed ID: 31916502
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore Modeling, 3D-QSAR and Molecular Docking of Furanochalcones as Inhibitors of Monoamine Oxidase-B.
Mathew B; Dev S; Suresh J; Mathew GE; Lakshmanan B; Haridas A; Fathima F; Krishnan GK
Cent Nerv Syst Agents Med Chem; 2016; 16(2):105-11. PubMed ID: 25788143
[TBL] [Abstract][Full Text] [Related]
18. Application of in-silico drug discovery techniques to discover a novel hit for target-specific inhibition of SARS-CoV-2 Mpro's revealed allosteric binding with MAO-B receptor: A theoretical study to find a cure for post-covid neurological disorder.
Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Masand VH; Ingle RG; Rathod VD; Gaikwad NM; Rashid S; Khatale PN; Burakale PV; Jawarkar RD
PLoS One; 2024; 19(1):e0286848. PubMed ID: 38227609
[TBL] [Abstract][Full Text] [Related]
19. Investigating the binding mechanism of piperidinyl ureas inhibitors based on the UBC12-DCN1 interaction by 3D-QSAR, molecular docking and molecular dynamics simulations.
Zhao J; Zang J; Yang J; Gao QB; Yan Y; Ma C; Chen Y; Ding L; Liu HM
J Biomol Struct Dyn; 2022 Apr; 40(6):2674-2688. PubMed ID: 33183176
[TBL] [Abstract][Full Text] [Related]
20. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors.
Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A
Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
